Table 1 |
|||||||||||
| HPV (HPV+), High Risk HPV (HR+) and multi infection in cytology and age subgroups | |||||||||||
| Normal | ASCUS | LSIL | HSIL | All | |||||||
| N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | ||
| Total | 537 | 62.6 (59.3–65.8) | 10 | 1.2 (0.4–1.9) | 298 | 34.7 (31.5–37.9) | 13 | 1.5 (0.7–2.3) | 858 | 27.1 (25.5–28.6) | |
| 14–25 | HPV+ | 129 | 24.0 (20.4–27.6) | 7 | 70 (–) | 221 | 74.2 (69.2–79.1) | 13 | 100 (–) | 370 | 43.1 (39.8–46.4) |
| Multiple | 39 | 7.3 (5.1–9.5) | 2 | 20 (0–44.8) | 115 | 38.6 (33.1–44.1) | 10 | 76.9 (–) | 171 | 19.9 (17.3–22.6) | |
| HR | 107 | 19.9 (16.5–23.3) | 7 | 70 (–) | 199 | 66.8 (61.4–72.1) | 13 | 100 (–) | 326 | 38 (34.7–41.2) | |
| Total | 1226 | 69.7 (67.5–71.8) | 26 | 1.5 (0.9–2.0) | 450 | 25.6 (23.5–27.6) | 58 | 3.3 (2.5–4.1) | 1760 | 55.5 (53.8–57.3) | |
| 26–46 | HPV+ | 165 | 13.5 (11.5–15.4) | 9 | 34.6 (16.3–52.9) | 342 | 76 (72.1–79.9) | 54 | 93.1 (–) | 570 | 32.4 (30.2–34.2) |
| Multiple | 39 | 3.2 (2.2–4.2) | 3 | 11.5 (0–23.8) | 148 | 32.9 (28.5–37.2) | 21 | 36.2 (23.8–48.6) | 211 | 12.0 (10.5–13.5) | |
| HR | 111 | 9.1 (7.4–10.2) | 9 | 34.6 (16.3–52.9) | 286 | 63.6 (59.1–68.0) | 49 | 84.5 (75.2–93.8) | 455 | 25.9 (23.8–27.9) | |
| Total | 455 | 82.4 (79.3–85.6) | 17 | 3.1 (1.6–4.5) | 73 | 13.2 (10.4–16.1) | 7 | 1.3 (0.3–2.2) | 552 | 17.4 (16.1–18.7) | |
| 47–70 | HPV+ | 54 | 11.9 (8.9–14.8) | 2 | 11.8 (0–27.1) | 48 | 65.8 (54.9–76.6) | 5 | 71.4 (–) | 109 | 19.7 (16.4–23.1) |
| Multiple | 17 | 3.7 (2.0–5.5) | 0 | 0 | 14 | 19.2 (10.1–28.2) | 0 | 0 | 31 | 5.6 (3.7–7.5) | |
| HR | 41 | 9.0 (6.4–11.6) | 2 | 11.8 (0–27.1) | 39 | 53.4 (42.0–64.9) | 5 | 71.4 (–) | 87 | 15.8 (12.7–18.8) | |
| Total | 2218 | 70 (68.4–71.6) | 53 | 1.7 (1.2–2.1) | 821 | 25.9 (24.4–27.4) | 78 | 2.5 (1.9–3) | 3170 | 100 (2.5–3.8) | |
| All | HPV+ | 348 | 15.7 (14.2–17.2) | 18 | 34 (21.2–46.7) | 611 | 74.4 (71.4–77.4) | 72 | 92.3 (86.4–98.2) | 1049 | 33.1 (31.5–34.7) |
| Multiple | 95 | 4.3 (3.4–5.1) | 5 | 9.4 (1.6–17.3) | 279 | 34 (30.7–37.2) | 30 | 38.5 (27.7–49.3) | 410 | 12.9 (11.8–14.1) | |
| HR | 259 | 11.7 (10.3–13.0) | 18 | 34 (21.2–46.7) | 524 | 63.8 (60.5–67.1) | 67 | 85.9 (78.2–93.6) | 868 | 27.4 (25.8–28.9) | |
Argyri et al. BMC Infectious Diseases 2013 13:53 doi:10.1186/1471-2334-13-53
